Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma

NCT00000660 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Sarcoma, Kaposi
HIV Infections

Interventions

DRUG: Etoposide

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]